Xu J - Search Results

1

[Sequential Treatment of Advanced Squamous Lung Cancer:  First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence].

Xu J, Liu X, Gao H, Guo W, Tang C, Li X, Li J, Qin H, Wang W, Qu L, Wang H, Yang H, Yang L. Xu J, et al. Zhongguo Fei Ai Za Zhi. 2015 May;18(5):308-14. doi: 10.3779/j.issn.1009-3419.2015.05.09. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25975302 Free PMC article. Chinese.

2

[Treatment of advanced NSCLC with unknown EGFR gene status --TKI or chemotherapy?].

Liu X, Xu J. Liu X, et al. Among authors: xu j. Zhongguo Fei Ai Za Zhi. 2014 Oct 20;17(10):709-14. doi: 10.3779/j.issn.1009-3419.2014.10.01. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25342036 Free PMC article. Review. Chinese.

3

The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Xu J, Xu B, Tang C, Li X, Qin H, Wang W, Wang H, Wang Z, Li L, Li Z, Gao H, He K, Liu X. Xu J, et al. Among authors: xu b. Dis Markers. 2017;2017:3160426. doi: 10.1155/2017/3160426. Epub 2017 Mar 13. Dis Markers. 2017. PMID: 28386154 Free PMC article.

4

Efficacy of different sequential patterns after crizotinib progression in advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Ma X, Yang S, Zhang K, Xu J, Lv P, Gao H, Qin H, Wang H, Liu X. Ma X, et al. Among authors: xu j. Thorac Cancer. 2022 Jun;13(12):1788-1794. doi: 10.1111/1759-7714.14455. Epub 2022 May 13. Thorac Cancer. 2022. PMID: 35560808 Free PMC article.

5

Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.

Ma X, Zhang K, Xu J, Gao H, Yang S, Qin H, Wang H, Gao F, Liu X. Ma X, et al. Among authors: xu j. Thorac Cancer. 2023 Jul;14(20):1980-1990. doi: 10.1111/1759-7714.14980. Epub 2023 Jun 2. Thorac Cancer. 2023. PMID: 37265111 Free PMC article.

6

rh-ES and Chemotherapy in Advanced Gastrointestinal Cancer in China: A Meta-analysis.

Xu J, Sun L, Luo S, Zhu G, Zhou Y, Jiang M, Wang M. Xu J, et al. Am J Med Sci. 2022 Apr;363(4):342-350. doi: 10.1016/j.amjms.2021.09.015. Epub 2021 Dec 24. Am J Med Sci. 2022. PMID: 34958746

7

Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer.

Xu J, Liu C, Wu X, Ma J. Xu J, et al. Chin Med J (Engl). 2023 Aug 5;136(15):1765-1782. doi: 10.1097/CM9.0000000000002536. Chin Med J (Engl). 2023. PMID: 37257112 Free PMC article. Review.

8

Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial-mesenchymal transition phenotype.

Xu J, Zhao X, He D, Wang J, Li W, Liu Y, Ma L, Jiang M, Teng Y, Wang Z, Gu M, Wu J, Wang Y, Yue W, Zhang S. Xu J, et al. J Cancer Res Clin Oncol. 2018 Aug;144(8):1413-1422. doi: 10.1007/s00432-018-2668-7. Epub 2018 May 24. J Cancer Res Clin Oncol. 2018. PMID: 29797219

9

A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.

Xu J, Zhang W, Tong J, Liu C, Zhang Q, Cao L, Yu J, Zhou A, Ma J. Xu J, et al. Cancer Immunol Immunother. 2024 Apr 20;73(6):107. doi: 10.1007/s00262-024-03680-y. Cancer Immunol Immunother. 2024. PMID: 38642109 Free PMC article. Clinical Trial.

10

Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.

Yuan H, Zhao Z, Xu J, Zhang R, Ma L, Han J, Zhao W, Guo M, Song Y. Yuan H, et al. Among authors: xu j. J Exp Clin Cancer Res. 2023 Sep 26;42(1):249. doi: 10.1186/s13046-023-02821-y. J Exp Clin Cancer Res. 2023. PMID: 37752569 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,264 results

Search Page

Filters